Oct-4 and Nanog Promote the Epithelial-Mesenchymal Transition of Breast Cancer Stem Cells and Are Associated With Poor Prognosis in Breast Cancer Patients

Oncotarget - United States
doi 10.18632/oncotarget.2506
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Circulating Tumor Cells With Stemness and Epithelial-To-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

NOTCH1 Is a Poor Prognostic Factor for Breast Cancer and Is Associated With Breast Cancer Stem Cells

OncoTargets and Therapy
OncologyPharmacology
2016English

Cooperation of Cancer Stem Cell Properties and Epithelial-Mesenchymal Transition in the Establishment of Breast Cancer Metastasis

Journal of Oncology
Oncology
2011English

Host Microenvironment in Breast Cancer Development: Epithelial–mesenchymal Transition in Breast Cancer Development

Breast Cancer Research
Cancer ResearchOncology
2003English

Combinatorial TGF-β Attenuation With Paclitaxel Inhibits the Epithelial-To-Mesenchymal Transition and Breast Cancer Stem-Like Cells

Oncotarget
Oncology
2015English

Deficiency of CCN5/WISP-2-Driven Program in Breast Cancer Promotes Cancer Epithelial Cells to Mesenchymal Stem Cells and Breast Cancer Growth

Scientific Reports
Multidisciplinary
2017English

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

Loss of CLCA4 Promotes Epithelial-To-Mesenchymal Transition in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy